DeepMed Research

Abbott Medical Devices Trading (Shanghai) Co., Ltd.

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients

Completed

Conditions: Heart Failure
Tachyarrhythmias
Sudden Cardiac Death

Interventions: Device: SJ4 connector and RV high voltage SJ4 lead

First Posted Date: 2009-07-16

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 1701

Registration Number: NCT00940888

Locations: 🇺🇸
The Cleveland Clinic Foundation, Cleveland, Ohio, United States

Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery

Not Applicable

Completed

Conditions: Peripheral Vascular Disease

Interventions: Device: SUPERA® Nitinol Stent System

First Posted Date: 2009-07-07

Last Posted Date: 2017-05-30

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 325

Registration Number: NCT00933270

Locations: 🇺🇸
Deborah Heart, Browns Mills, New Jersey, United States
🇺🇸
Maine Medical Center, Portland, Maine, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

and more 46 locations

BOOST - Benefit of Frequent Optimization After Cardiac Resynchronization Therapy Device Replacement

Not Applicable

Terminated

Conditions: Heart Failure

Interventions: Device: QuickOpt - SJM CRT (Group 1)
Device: Control - SJM CRT (Group 2)

First Posted Date: 2009-06-29

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 17

Registration Number: NCT00929474

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States
🇺🇸
Hattiesburg Clinic, P.A./Southern Heart Center, Hattiesburg, Mississippi, United States

Therapy Cool Path Ablate VT

Not Applicable

Terminated

Conditions: Ischemic Ventricular Tachycardia

Interventions: Device: Therapy Cool Path Duo Cardiac Ablation System

First Posted Date: 2009-06-22

Last Posted Date: 2019-04-17

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 20

Registration Number: NCT00925522

Locations: 🇺🇸
Kansas University Medical Center, Kansas City, Kansas, United States
🇺🇸
Loyola University Medical Center, Maywood, Illinois, United States
🇺🇸
Krannert Institute of Cardiology, Indianapolis, Indiana, United States

and more 2 locations

Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) Therapy

Not Applicable

Completed

Conditions: Ventricular Tachycardia
Left Ventricular Dysfunction
Coronary Artery Disease

Interventions: Procedure: Substrate modification
Procedure: VT ablation
Procedure: ICD Implantation

First Posted Date: 2009-06-12

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 110

Registration Number: NCT00919373

Locations: 🇩🇪
Medizinische Fakultät der Universität Magdeburg, Magdeburg, Saxony-Anhalt, Germany
🇩🇪
Herz- und Gefäßklinik Bad Neustadt, Bad Neustadt, Bavaria, Germany
🇩🇪
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Hesse, Germany

and more 13 locations

QuickOptTM Study - Using the QuickOptTM Method for Timing Cycle Optimization

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Device: QuickOpt

First Posted Date: 2009-06-11

Last Posted Date: 2019-01-30

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 100

Registration Number: NCT00918294

Locations: 🇨🇳
Fu Wai Hospital, Beijing, China

Detect Fluid Early From Intra-thoracic Impedance Monitoring

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Device: Impedance Monitoring Feature

First Posted Date: 2009-06-10

Last Posted Date: 2019-02-19

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 162

Registration Number: NCT00916929

Locations: 🇺🇸
York Hospital, York, Pennsylvania, United States
🇺🇸
North Mississippi Medical Center, Tupelo, Mississippi, United States
🇺🇸
Deborah Heart and Lung Center, Browns Mills, New Jersey, United States

and more 31 locations

SPIRIT PRIME Clinical Trial

Phase 3

Completed

Conditions: Coronary Artery Disease
Coronary Artery Stenosis
Myocardial Ischemia
Coronary Restenosis
Coronary Disease

Interventions: Device: Core size Xience Prime
Device: Xience Prime Long Lesion (LL)

First Posted Date: 2009-06-09

Last Posted Date: 2015-06-08

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 525

Registration Number: NCT00916370

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸
Riverside Methodist Hospital, Columbus, Ohio, United States

and more 59 locations

Optimal EGM Configuration for Morphology Discrimination

Terminated

Conditions: Premature Ventricular Complexes

Interventions: Other: Pacing interventions

First Posted Date: 2009-04-27

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 3

Registration Number: NCT00888667

Locations: 🇨🇦
St Michael's Hospital, Toronto, Ontario, Canada

Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period

Phase 3

Completed

Conditions: Coronary Restenosis

Interventions: Device: Xience V®

First Posted Date: 2009-04-16

Last Posted Date: 2012-09-06

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 102

Registration Number: NCT00882219

Locations: 🇫🇷
Hopital de Rangueil - Chu, Toulouse, France

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy